EGM
CNCE

Engineers Gate Manager’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Engineers Gate Manager’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,600
Closed -$128K – 2152
2021
Q1 		$128K Buy
+25,600
New +$207K 0.01% 1672

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Engineers Gate Manager's CNCE Position: Q2 2021 in Review

Engineers Gate Manager sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 25,600 shares — an estimated $128K sold.

Engineers Gate Manager first reported a position in CNCE in Q1 2021 and held it in 1 quarter. The position peaked at $128K in Q1 2021. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • Engineers Gate Manager reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 25,600 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $128K.
  • Engineers Gate Manager first reported a position in Concert Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
  • Engineers Gate Manager's Concert Pharmaceuticals, Inc. position peaked at $128K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.